policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
policy
Therapeutic medications in racehorses
Health care decisions for individual horses are the responsibility of the veterinarian, trainer, and owner and must have the best interests of the…
policy
Therapeutic medications in competition equids
The AVMA condemns the administration of non-therapeutic or unprescribed medications to competition equids. Health care decisions regarding individual…